Setoxlin CR-paroxetine prolonged release tablets 12.5 mg

Buy Setoxlin CR-paroxetine prolonged release tablets 12.5 mg for Wholesale Order

What is Setoxlin CR-paroxetine prolonged release tablets 12.5 mg?

Setoxlin CR-paroxetine prolonged release tablets 12.5 mg are a pharmaceutical formulation of paroxetine, a selective serotonin reuptake inhibitor (SSRI). This compound is primarily used in the treatment of major depressive disorder, anxiety disorders, and obsessive-compulsive disorder. Its prolonged release formulation allows for sustained therapeutic effects over an extended period, enhancing patient compliance. Regulatory bodies classify this compound under prescription medications, necessitating careful adherence to manufacturing guidelines and quality standards.

What Are the Applications of Setoxlin CR-paroxetine prolonged release tablets 12.5 mg?

• Effective treatment for major depressive disorder.
• Management of generalized anxiety disorder.
• Used in clinical settings for research on SSRIs.
• Formulation development for controlled release therapies.
• Supports studies in pharmacology and mental health research.

Why Choose Pharmint as Your Setoxlin CR-paroxetine prolonged release tablets 12.5 mg Supplier?

Pharmint offers global sourcing capabilities, ensuring access to high-quality Setoxlin CR-paroxetine tablets. We provide:

• Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS) for regulatory compliance.
• Bulk availability for large-scale procurement.
• Streamlined lead times and dedicated export support.
• Robust quality assurance protocols to meet international standards.

Storage & Handling Guidelines for Setoxlin CR-paroxetine prolonged release tablets 12.5 mg

Store Setoxlin CR-paroxetine tablets in a cool, dry place away from direct sunlight. Optimal storage conditions are between 15°C to 25°C (59°F to 77°F). Ensure the packaging is airtight to prevent moisture exposure, particularly for bulk or research-grade materials.

Regulatory, Documentation & Export Information

This product is not classified as a controlled precursor; however, it may require an end-use declaration for certain applications. Available documentation includes:

• Certificates of Analysis (COA)
• Material Safety Data Sheets (MSDS)
• Drug Master Files (DMF) if applicable

Setoxlin CR-paroxetine prolonged release tablets 12.5 mg FAQs

Where to Buy Setoxlin CR-paroxetine prolonged release tablets 12.5 mg for bulk?

You can purchase Setoxlin CR-paroxetine tablets in bulk directly from Pharmint, ensuring compliance and quality assurance for your procurement needs.

What are the handling precautions for Setoxlin CR-paroxetine tablets?

Always handle Setoxlin tablets with care, using appropriate PPE. Avoid exposure to moisture and light to maintain product integrity.

Is Setoxlin CR-paroxetine subject to export regulations?

This product is not a controlled substance; however, compliance with local regulations is advised for international shipping. Consult with Pharmint for guidance.

What quality assurance measures does Pharmint implement?

Pharmint adheres to stringent quality assurance protocols, providing COA and MSDS for all products to ensure safety and compliance.

Can Setoxlin CR-paroxetine tablets be used in research settings?

Yes, these tablets are suitable for clinical research and can support studies on SSRIs and their therapeutic applications in mental health.